Journal Menu
► ▼ Journal Menu-
- Marine Drugs Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal Browser-
arrow_forward_ios
Forthcoming issue
arrow_forward_ios Current issue - Vol. 22 (2024)
- Vol. 21 (2023)
- Vol. 20 (2022)
- Vol. 19 (2021)
- Vol. 18 (2020)
- Vol. 17 (2019)
- Vol. 16 (2018)
- Vol. 15 (2017)
- Vol. 14 (2016)
- Vol. 13 (2015)
- Vol. 12 (2014)
- Vol. 11 (2013)
- Vol. 10 (2012)
- Vol. 9 (2011)
- Vol. 8 (2010)
- Vol. 7 (2009)
- Vol. 6 (2008)
- Vol. 5 (2007)
- Vol. 4 (2006)
- Vol. 3 (2005)
- Vol. 2 (2004)
- Vol. 1 (2003)
Need Help?
Announcements
17 June 2021
Marine Drugs Has Received an Increased CiteScore of 6.4
It is our great pleasure to announce that Marine Drugs (ISSN 1660-3397) has received an increased CiteScore (2020 Scopus data) of 6.4 for the year 2020, ranked as a Q1 journal in three categories:
- Percentile 86%, Q1, in Category "Pharmacology, Toxicology and Pharmaceutics (miscellaneous)";
- Percentile 83%, Q1, in Category "Pharmaceutical Science";
- Percentile 78%, Q1, in Category "Drug Discovery".
We would like to extend our sincerest gratitude to all authors, reviewers, and editors who have contributed to the journal and enabled this significant milestone!
